Contact: Jade Boyd
Caption: Rice University chemist Zachary Ball (left) and graduate student Matthew Minus have begun working with colleagues at Baylor College of Medicine to develop a new approach to design drug candidates that inhibit STAT3, a therapeutic target that may provide a treatment option for drug-resistant cancers.
Credit: Jeff Fitlow/Rice University
Usage Restrictions: Must credit: Jeff Fitlow/Rice University
Related news release: Pinning protein could answer provocative cancer question